TCL Archive In Brief: Peck Joins GenPharm board; Dallas Hospital Selects director For New BMT Program February 11, 1994
TCL Archive ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial. September 8, 2006
TCL Archive NCI Accused Of forsaking Its Mission In House Hearing On Screening Statement March 18, 1994